Sp560
TREATMENT OF TYPE 1 AND TYPE 2 AIP: CORTICOSTEROIDS, IMMONOMODULATORS OR RITUXIMAB?
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
Session will review the diagnosis and treatment of autoimmune pancreatitis.
Session will review the diagnosis and treatment of autoimmune pancreatitis.
Presenter
Ohio State University
Tracks
Related Products
AGA Clinical Chronic Pancreatitis
SOCIETY: AGA
GERMLINE MULTIGENE PANEL TESTING IN ACUTE AND CHRONIC PANCREATITIS
Germline genetic testing is recommended for younger patients with idiopathic pancreatitis, but there is no consensus recommendation for those over age 35. We aimed to analyze the results of genetic testing for pancreatic genetic mutations using a large dataset including all ages…
INCIDENCE OF EXOCRINE PANCREATIC INSUFFICIENCY AT 3 MONTHS AFTER ACUTE PANCREATITIS: A MULTICENTER PROSPECTIVE STUDY
Background: The incidence of hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has been increasing recently. Plasmapheresis can effectively remove triglyceride(TG) from plasma, but its clinical value in HTG-AP is unclear due to the lack of solid evidence…
INTRODUCTION
SOCIETY: AGA
